Hiroshi Yamagami, M.D., Ph.D.,presents LB 21

Hiroshi Yamagami, M.D., Ph.D., presents Cilostazol versus Other Anti-platelet Drugs for the In-stent Restenosis After Carotid Artery Stenting: The Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE) Trial during ME III, Closing Main Event at the American Heart Association / American Stroke Association International Stroke Conference at the Los Angeles Convention Center.

Please see AHA/ASA Multimedia Materials Usage Policy.

I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use

Download (2.2 MB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED